CHDS faculty Ankur Pandya outlined how economic evaluation methods could be used to improve the process of making difficult policy choices around COVID-19 in a recently co-authored Perspective in the New England Journal of Medicine. Improving ventilation in indoor spaces will likely reduce COVID-19 transmission but will require substantial costs, for example, resulting in a trade-off that can be formally assessed using economic evaluation methods. Pandya and his co-author Govind Persad (University of Denver Sturm College of Law) discuss the advantages and limitations of aggregating outcomes, such as health gains and costs, into a single metric that can be used to guide decision-making. They also discuss the role of economic evaluation in assessing uncertainty and dimensions related to health equity.
Learn more: Read the article, A Comprehensive Covid-19 Response – The Need for Economic Evaluation
Learn more: Explore the Resource Pack: Extended Cost-Effectiveness Analysis
Learn more: Explore the Resource Pack: Introduction to Benefit-Cost Analysis
Related news: Valuing COVID-19 Morbidity Risks
Related news: CHDS Seminar with Dr. Anna Vassall